Pharmacology

IMMUNOLOGY

Butantan’s dengue vaccine is 80% effective

The vaccine offered protection against two serotypes of the virus in the final phase of human trials

By

IMMUNOLOGY

Construction begins on Brazil’s new National Vaccine Center in Belo Horizonte

The institution will function as a link between basic immunobiological research and final products

By

Health

Immune cells increase pain from nerve damage

Immune cells increase chronic pain from nerve damage

By

RETROSPECT

The science rebel

Credited with discovering bradykinin, Maurício Oscar da Rocha e Silva fought to overcome the narrow-mindedness within scientific institutions before his death 40 years ago

By

IMMUNOLOGY

Three Brazilian COVID-19 vaccines begin human testing

The three candidates use different technologies; two have already completed the first phase of clinical trials

By

Chemistry

Collaboration to fight drug resistance

Seven pharmaceutical companies pledge to share surveillance data on antimicrobial resistance

By

PUBLIC SPENDING

SUS to save money as patent extensions come to an end

Expenditure on nine drugs could be reduced by R$3.9 billion, according to UFRJ estimates

By

COVID-19

Anti-coronavirus semiconductors

Nanotechnological materials emerge as promising alternatives in the battle against SARS-CoV-2 and future pandemics

By

photolab

Light sensors

In the lab, zebrafish larvae become covered in green glowing dots when exposed to certain drugs or pollutants

By

Health

Nasal COVID-19 vaccine

Research into intranasal vaccines against Covid-19 is advancing

By

COVID-19

Another step towards a universal vaccine

Clinical trials begin for broad-spectrum vaccines designed to offer protection against multiple coronaviruses

By

COVID-19

New coronavirus drugs

Pharmaceuticals announce orally administered drugs designed to treat the disease caused by SARS-Cov-2

By

Health

Focus on the bacillus

Fast, portable, and sensitive, a new test could be a useful tool for preventing leprosy and helping with early diagnosis.

By

COVID-19

The quest for a Brazilian vaccine

Researchers are testing a range of technologies, but few initiatives will receive the funding needed for costly phase 3 clinical trials

By

Covid-19

New COVID-19 drug

An antiviral pill developed by pharmaceutical company Pfizer reduced the risk of death and hospitalization in people recently diagnosed with Covid-19 by 89% compared to a placebo

By

COVID-19

Two vaccines safe for children

The CoronaVac vaccine, produced in Brazil by the Butantan Institute, is safe for children and adolescents, with no major side effects

By

Pharmacology

University of Oxford in Brazil

The Brazilian Ministry of Health signed a term of commitment with the University of Oxford, UK, to establish a clinical research and development center in Rio de Janeiro for the British institution’s drugs and vaccines

By

Nuclear medicine

Radiopharmaceuticals under threat

Radiopharmaceutical crisis leads to debate over production model

By

HEALTH

Pioneering immunization

Malaria vaccine recommended for children in Africa by the WHO is the first to protect humans from a parasite

By

Covid-19

A promising antiviral

Molnupiravir reduced COVID-19’s hospitalization and death rate by nearly half in a phase 3 clinical trial of people with mild to moderate infections

By

COVID-19

First DNA-based vaccine

India has developed and approved the first COVID-19 vaccine based on DNA technology

By

COVID-19

Still too soon for booster doses

An international group of scientists argued against the idea of giving the majority of the population COVID-19 vaccine booster doses

By

Physics/Chemistry

Free passage through the skin

Simulations indicate that applying an electric field stimulates the formation of "blisters" that turn the epidermis into a gateway for drugs to enter the body

By

Covid-19

Delta advances

Delta variant threatening control of the COVID-19 pandemic

By

Covid-19

Pfizer vaccine to be made in Brazil

Pfizer vaccine to be made in Brazil

By

Careers

Scientist in training

Nursing student at UFMG awarded for her undergraduate research on the treatment of tegumentary leishmaniasis

By

COVID-19

ButanVac clinical trials begin

ButanVac, the vaccine candidate that will be produced by the Butantan Institute entirely in Brazil with no need to import any ingredients, has begun clinical trials

By

Pharmacology

New Alzheimer’s drug sparks controversy

A new compound designed to fight Alzheimer's disease is causing controversy

By

COVID-19

Vaccines in the real world

CoronaVac and Covishield effectiveness tested in Serrana and Botucatu, two towns in the state of São Paulo

By

COVID-19

Limited use

ANVISA authorizes the use of three COVID-19 drugs, but they are expensive and designed only for specific situations

By